2023-09-14 04:14:00
Economy/Finance14 Sept. ’23 9:142023-09-14
APCO Reveals Business Direction for 3Q23, Reports Sales Growth in All Product Groups
Asian Phytoceuticals Public Company Limited (APCO), the owner of a natural innovation business for health and beauty, has announced its business direction for the third quarter of 2023. The company has reported sales growth in all product groups, demonstrating a positive trend in its operations. APCO is focused on improving the quality of life through research, development, production, and distribution of innovative health and beauty products.
Under the leadership of Prof. Dr. Pichet Wiriyachitra, the Chief Executive Officer of APCO, the company aims to expand its customer base domestically and abroad. One of its notable innovations is the Wattanajiva Innovation, which has reached a milestone of 12,000 members. This innovation focuses on upgrading cancer therapy formulas and has the potential to revolutionize cancer treatment. Additionally, APCO has joined hands with partners to export the Bye Bye HIV/AIDS product to China, reinforcing its target of achieving 30% revenue growth while maintaining a gross profit margin of 80%.
In the first half of 2023, APCO generated a total revenue of 151.76 million baht, resulting in a profit of 58.42 million baht, representing a remarkable growth rate of 80.71%.
Prof. Dr. Pichet Wiriyachitra emphasized the company’s commitment to delivering innovative products that target a wide range of health concerns. The company plans to focus on developing anti-aging and anti-aging products that work without the risk of cancer or infection. APCO’s research has proven that these products stimulate the immune system CD4 and Killer T Cell CD8, providing a unique approach to reversing aging and delaying its onset.
Buoyed by its success, APCO is set to send its anti-aging and anti-aging innovation products to Youthlocked Company Limited in Singapore on September 15th. Prof. Dr. Pichet Wiriyachitra will also be present at a product launch event on October 17, 2023, where he will lecture on the efficiency of the innovation. Youthlocked anticipates placing another order within this year, and APCO plans to expand its distribution to Vietnam, Philippines, Indonesia, and Malaysia.
One of APCO’s cultural innovations in Thailand is the Wattanacheeva product, which has witnessed a surge in membership, currently reaching 12,000. The company is confident that this number will continue to grow rapidly due to marketing and public relations activities. An International Culture Day event is scheduled for October 2, 2023, at Swissotel Hotel, Ratchadaphisek Road.
In the field of cancer treatment, APCO has developed a new and highly efficient formula. This formula stimulates Super CD4 and Super CD8, aiding individuals with weakened immune systems due to mRNA vaccination. This development is expected to play a crucial role in driving continuous growth in APCO’s operating results.
APCO has also made significant strides in addressing HIV/AIDS care. The company can now provide Bye Bye HIV to 44 infected individuals, marking a groundbreaking achievement for Thai national innovation. This breakthrough has garnered confidence not just locally but also abroad, particularly in China.
To further its efforts, APCO will collaborate with its partner, NP Holding Company Limited, to send the “special formula KTCEL” to infected individuals in China. Additionally, plans are underway to bring infected individuals to Bangkok for care, in collaboration with associations and foundations dedicated to supporting 400,000 infected individuals in China.
With these strategic plans in place, APCO anticipates achieving a 30% increase in operating results in 2023 while maintaining a gross profit margin of 80%.
Source: Worklink Da Agency
Symbol: APCO]
#APCO #accelerates #sales #antiaging #cancer #HIVAIDS #reinforcing #target #revenue #growth #maintaining #gross #profit #margin